DOI: 10.1055/s-00000069

Seminars in Liver Disease

Issue 02 · Volume 34 · May 2014 DOI: 10.1055/s-004-27077 Drug-Induced Liver Injury Guest Editors, Naga Chalasani, MD, and Paul H. Hayashi, MD, MPH

Foreword

113
Chalasani, Naga; Hayashi, Paul H.: Slow but Steady Progress in a Field with Many Knowledge Gaps

115
Björnsson, Einar S.: Epidemiology and Risk Factors for Idiosyncratic Drug-Induced Liver Injury
123
Urban, Thomas J.; Daly, Ann K.; Aithal, Guruprasad P.: Genetic Basis of Drug-Induced Liver Injury: Present and Future
134
Hayashi, Paul H.; Fontana, Robert J.: Clinical Features, Diagnosis, and Natural History of Drug-Induced Liver Injury
145
Devarbhavi, Harshad; Andrade, Raúl J.: Drug-Induced Liver Injury Due to Antimicrobials, Central Nervous System Agents, and Nonsteroidal Anti-Inflammatory Drugs
162
Bahirwani, Ranjeeta; Reddy, K. Rajender: Drug-Induced Liver Injury due to Cancer Chemotherapeutic Agents
172
Navarro, Victor J.; Lucena, M. Isabel: Hepatotoxicity Induced by Herbal and Dietary Supplements
194
deLemos, Andrew S.; Foureau, David M.; Jacobs, Carl; Ahrens, Will; Russo, Mark W.; Bonkovsky, Herbert L.: Drug-Induced Liver Injury with Autoimmune Features
205
Amacher, David E.; Chalasani, Naga: Drug-Induced Hepatic Steatosis
215
Avigan, Mark I.: DILI and Drug Development: A Regulatory Perspective
227
Regev, Arie: Drug-Induced Liver Injury and Drug Development: Industry Perspective

Diagnostic Problems in Hepatology

240
Ghabril, Marwan; Vuppalanchi, Raj: Drug-Induced Nodular Regenerative Hyperplasia
246
Levine, Calley; Trivedi, Anshu; Thung, Swan N.; Perumalswami, Ponni V.: Severe Ductopenia and Cholestasis from Levofloxacin Drug-Induced Liver Injury: A Case Report and Review

Erratum

252
Welzel, Tania Mara; Zeuzem, Stefan: Interferon-Free Strategies without a Nucleoside/Nucleotide Analogue